ArabFinance: Memphis Pharmaceutical posted a net profit of EGP 41.37 million in the fiscal year (FY) 2020/2021, according to the company’s financial statements filed to the Egyptian Exchange.
This marked a Year on Year (YoY) rise of 137% when compared to EGP 17.41 million in the FY 2019/2020.
The company’s unaudited financials showed that the company posted a net profit of EGP 25.373 million in quarter one (Q1) of 2021.
Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.